Insider selling
Traded Feb 18, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
A Genpact director sold $5.97M of Genpact shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Sep 30, 2024 (Q3 2024) · Filed Feb 4, 2025
12 tracked managers disclosed the same change for Q3 2024. From a 13F filed Feb 4, 2025 covering holdings at Sep 30, 2024 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Reduced
Compared with the manager's Q2 2024 13F
178,885
161,447
−9.7%
Share count drives classification; reported value also moves with price
0.19%
Within the filing's reported positions, not the manager's total assets
12
For Q3 2024
Insider selling
Traded Feb 18, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
A Genpact director sold $5.97M of Genpact shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Feb 13, 2025 · filed 5 days laterNot reported under a pre-arranged trading plan
Genpact's SVP & Chief Legal Officer sold $221K of Genpact shares. The filing does not indicate a pre-arranged trading plan.
Fund moves
11 tracked managers disclosed the same change for Q4 2024. From a 13F filed Feb 14, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.